Since the 1990s, clinical research has been carried out by a study group on the Ministry of Health, Labour and Welfare, suggested that ultrahigh-dose mecobalamin, which is respectively 50 and 100 times the approved dosage of Methycobal, could have a clinical effect in ALS, and Eisai then conducted the Phase II/III clinical trial (Study 761) from 2006
Notably, although strong experimental evidence especially from animal studies supports these pathways, to date no direct evidence indicates any of these pathways are present in a specific aging-associated diabetic phenotype in humans
Research Summary Bundle of two separate vials BPC-157 20mg and TB-500 20mg
Specifically, we proposed that ASCs must use the HQR system for data submission for any PRO-PM that we adopt for the ASCQR Program measure set
no universal prepared-solution condition is inferred here
Reference material for research use only